Skip to main content
. 2018 Sep 24;8:14294. doi: 10.1038/s41598-018-32428-9

Figure 1.

Figure 1

Skp2 is overexpressed in osteosarcoma cell lines and high Skp2 levels are correlated with a worse prognosis. (A) Quantitative RT-PCR. Skp2 mRNA expression in 5 standard and 8 patient-derived osteosarcoma cell lines was significantly increased compared to normal human osteoblasts (NHOst). (B,C) Skp2 protein levels were elevated in standard (B) and patient-derived (C) osteosarcoma cell lines compared to NHOsts. (D) Kaplan-Meier analysis. Raw Skp2 expression data was retrieved from NCBI GEO and correlated with survival data from the R2 platform. The median Skp2 mRNA expression was used as a cutoff to distinguish low vs. high expression. High Skp2 expression correlated significantly with a worse metastasis-free survival. (E) Tissue microarrays. Overall survival was compared in osteosarcoma patients whose tumors expressed low (- and +) vs. high (++ and +++) Skp2 (negative =<1% stained cells; (+) = 1–10%; (++) = 10–50%; (+++) =>50%). By log-rank test, the high Skp2 expression group sustained a worse overall survival than the low expression group. (F) Representative pictures of IHC scoring for Skp2. Statistical significance is indicated by: *p < 0.05, **p < 0.01, ***p < 0.001. Column: mean; Error bars: SD.